Millions of people globally suffer from food allergies or related diseases like celiac. Far more common, however, are mild food allergies and sensitivities that can still significantly impact a person’s quality of life. Binur and fellow co-founder Yanay Ofran began Ukko in 2016 in an attempt to shift the paradigm on food allergies. The company recently announced a $40M Series B funding round to advance its efforts in ending food allergies for good. Dr. Onyinye Iweala says that current immunotherapy approaches are only available for a segment of ... [+] people with severe allergies and sees promise in Ukko’s novel approach to alleviating food allergies.

Source: Forbes January 27, 2021 12:00 UTC